Ngā hua rapu kaituhi

1

Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus. mā Ishizaki, R, Langlois, A J, Bolognesi, D P

I whakaputaina 1975

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Reaction of Chick Embryo Cells Infected with Leukosis Strain MC29 Virus with Fluorescein-Labeled Antibody mā Fritz, Robert B., Langlois, A. J., Beard, J. W.

I whakaputaina 1969

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Massive direct conversion of chick embryo cells by strain MC29 avian leukosis virus. mā Langlois, A J, Sankaran, S, Hsiung, P H, Beard, J W

I whakaputaina 1967

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Component of Strain MC29 Avian Leukosis Virus with the Property of Defectiveness mā Ishizaki, R., Langlois, A. J., Chabot, J., Beard, J. W.

I whakaputaina 1971

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. mā Lyerly, H K, Matthews, T J, Langlois, A J, Bolognesi, D P, Weinhold, K J

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

In Vitro Chick Embryo Cell Response to Strain MC29 Avian Leukosis Virus mā Bolognesi, D. P., Langlois, A. J., Sverak, L., Bonar, R. A., Beard, J. W.

I whakaputaina 1968

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. mā Matthews, T J, Weinhold, K J, Lyerly, H K, Langlois, A J, Wigzell, H, Bolognesi, D P

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. mā Schrier, R D, Gnann, J W, Langlois, A J, Shriver, K, Nelson, J A, Oldstone, M B

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. mā Skinner, M A, Langlois, A J, McDanal, C B, McDougal, J S, Bolognesi, D P, Matthews, T J

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. mā Matthews, T J, Langlois, A J, Robey, W G, Chang, N T, Gallo, R C, Fischinger, P J, Bolognesi, D P

I whakaputaina 1986

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. mā St Clair, M H, Richards, C A, Spector, T, Weinhold, K J, Miller, W H, Langlois, A J, Furman, P A

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. mā Shadduck, P P, Weinberg, J B, Haney, A F, Bartlett, J A, Langlois, A J, Bolognesi, D P, Matthews, T J

I whakaputaina 1991

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. mā Palker, T J, Clark, M E, Langlois, A J, Matthews, T J, Weinhold, K J, Randall, R R, Bolognesi, D P, Haynes, B F

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. mā Berman, P W, Matthews, T J, Riddle, L, Champe, M, Hobbs, M R, Nakamura, G R, Mercer, J, Eastman, D J, Lucas, C, Langlois, A J

I whakaputaina 1992

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. mā Javaherian, K, Langlois, A J, Schmidt, S, Kaufmann, M, Cates, N, Langedijk, J P, Meloen, R H, Desrosiers, R C, Burns, D P, Bolognesi, D P

I whakaputaina 1992

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. mā Palker, T J, Matthews, T J, Clark, M E, Cianciolo, G J, Randall, R R, Langlois, A J, White, G C, Safai, B, Snyderman, R, Bolognesi, D P

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. mā Javaherian, K, Langlois, A J, McDanal, C, Ross, K L, Eckler, L I, Jellis, C L, Profy, A T, Rusche, J R, Bolognesi, D P, Putney, S D

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. mā Rusche, J R, Lynn, D L, Robert-Guroff, M, Langlois, A J, Lyerly, H K, Carson, H, Krohn, K, Ranki, A, Gallo, R C, Bolognesi, D P

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. mā Javaherian, K, Langlois, A J, Montefiori, D C, Kent, K A, Ryan, K A, Wyman, P D, Stott, J, Bolognesi, D P, Murphey-Corb, M, Larosa, G J

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. mā Arthur, L O, Bess, J W, Waters, D J, Pyle, S W, Kelliher, J C, Nara, P L, Krohn, K, Robey, W G, Langlois, A J, Gallo, R C

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Langlois, A J

Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus. mā Ishizaki, R, Langlois, A J, Bolognesi, D P

Reaction of Chick Embryo Cells Infected with Leukosis Strain MC29 Virus with Fluorescein-Labeled Antibody mā Fritz, Robert B., Langlois, A. J., Beard, J. W.

Massive direct conversion of chick embryo cells by strain MC29 avian leukosis virus. mā Langlois, A J, Sankaran, S, Hsiung, P H, Beard, J W

Component of Strain MC29 Avian Leukosis Virus with the Property of Defectiveness mā Ishizaki, R., Langlois, A. J., Chabot, J., Beard, J. W.

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. mā Lyerly, H K, Matthews, T J, Langlois, A J, Bolognesi, D P, Weinhold, K J

In Vitro Chick Embryo Cell Response to Strain MC29 Avian Leukosis Virus mā Bolognesi, D. P., Langlois, A. J., Sverak, L., Bonar, R. A., Beard, J. W.

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. mā Matthews, T J, Weinhold, K J, Lyerly, H K, Langlois, A J, Wigzell, H, Bolognesi, D P

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. mā Schrier, R D, Gnann, J W, Langlois, A J, Shriver, K, Nelson, J A, Oldstone, M B

Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. mā Skinner, M A, Langlois, A J, McDanal, C B, McDougal, J S, Bolognesi, D P, Matthews, T J

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. mā Matthews, T J, Langlois, A J, Robey, W G, Chang, N T, Gallo, R C, Fischinger, P J, Bolognesi, D P

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. mā St Clair, M H, Richards, C A, Spector, T, Weinhold, K J, Miller, W H, Langlois, A J, Furman, P A

Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. mā Shadduck, P P, Weinberg, J B, Haney, A F, Bartlett, J A, Langlois, A J, Bolognesi, D P, Matthews, T J

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. mā Palker, T J, Clark, M E, Langlois, A J, Matthews, T J, Weinhold, K J, Randall, R R, Bolognesi, D P, Haynes, B F

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. mā Berman, P W, Matthews, T J, Riddle, L, Champe, M, Hobbs, M R, Nakamura, G R, Mercer, J, Eastman, D J, Lucas, C, Langlois, A J

The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. mā Javaherian, K, Langlois, A J, Schmidt, S, Kaufmann, M, Cates, N, Langedijk, J P, Meloen, R H, Desrosiers, R C, Burns, D P, Bolognesi, D P

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. mā Palker, T J, Matthews, T J, Clark, M E, Cianciolo, G J, Randall, R R, Langlois, A J, White, G C, Safai, B, Snyderman, R, Bolognesi, D P

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. mā Javaherian, K, Langlois, A J, McDanal, C, Ross, K L, Eckler, L I, Jellis, C L, Profy, A T, Rusche, J R, Bolognesi, D P, Putney, S D

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. mā Rusche, J R, Lynn, D L, Robert-Guroff, M, Langlois, A J, Lyerly, H K, Carson, H, Krohn, K, Ranki, A, Gallo, R C, Bolognesi, D P

Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. mā Javaherian, K, Langlois, A J, Montefiori, D C, Kent, K A, Ryan, K A, Wyman, P D, Stott, J, Bolognesi, D P, Murphey-Corb, M, Larosa, G J

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. mā Arthur, L O, Bess, J W, Waters, D J, Pyle, S W, Kelliher, J C, Nara, P L, Krohn, K, Robey, W G, Langlois, A J, Gallo, R C

Ngā utauta rapu: